• Username (E-mail)
  • Password
Dow 19,805 -0.1%  EStoxx50 3,294 0.3%  Nikkei 19,072 0.9%  EUR 1.0639 0.1% 
Nasdaq 5,556 0.3%  FTSE100 7,248 0.4%  Yen 114.6370 0.1%  Oil 54.4 0.3% 
S&P500 2,272 0.2%  DAX 11,599 0.5%  GBP 1.2275 0.1%  Gold 1,201 -1.5% 

Vertex Pharmaceuticals share [Symbol: VRTX / ISIN: US92532F1003]

Realtimequote Vertex Pharmaceuticals Inc. in USD

Exchange Market
82.49
Last
137,064
Volume
Time 03:59 PM
01/18/2017 03:59:58 PM UTC-0500
activate push

Stock Price Vertex Pharmaceuticals Inc. in USD

Activate push
82.52 USD 0.97 USD 1.19 %
Trade Time 8:10 PM Trade Date 1/18/2017
Daily High 82.83 Open 81.88
Daily Low 81.88 Prev. Close 81.55
52-week High 103.68 Volume (Qty.) 604,132
52-week Low 71.50 Market Cap (USD) 20.18 B
52-week Perf.
Exchange

Analyst Opinions for Vertex Pharmaceuticals Inc.

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
12/14/12
Vertex Pharmaceuticals Goldman Sachs Group Inc.
12/05/12
Vertex Pharmaceuticals RBC Capital Markets
11/13/12
Vertex Pharmaceuticals Credit Suisse Group
11/05/12
Vertex Pharmaceuticals Goldman Sachs Group Inc.
11/02/12
Vertex Pharmaceuticals UBS AG

Moody's Rating for Vertex Pharmaceuticals Inc.

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating
Rating Update
Date of Rating
Rating Office -

Profile Vertex Pharmaceuticals Inc.

Company Profile
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
pagehit

Add or Edit Instrument

Vertex Pharmaceuticals Chart - 1 Year - NAS
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: NAS
  • Chart Options

Estimates for Vertex Pharmaceuticals

2015 2016e 2017e
Dividend - - -
Dividend Yield in % - - -
P/E Ratio -114.94 99.98 39.07
EPS -1.11 0.78 2.00

Vertex Pharmaceuticals Key Figures

Market Cap (USD) 20.18 B
Free Float in % 99.46
Number of Shares (Mio.) 248.03
Cash Flow per Share -1.35
Book Value per Share 2.86
60-Days Volatility 45.6
P/B Ratio 44.53

Base Data Vertex Pharmaceuticals

Symbol VRTX
ISIN US92532F1003
Indices BX Swiss - USA, NASDAQ 100, NASDAQ Comp., S&P 500

About the Company Vertex Pharmaceuticals

Country USA

Vertex Pharmaceuticals Historical Prices

01/17/2017
01/17/2017 06:00:00 PM UTC-0500
82.52 604,132
01/16/2017
01/16/2017 06:00:00 PM UTC-0500
81.55 559,984
01/12/2017
01/12/2017 06:00:00 PM UTC-0500
83.17 478,872
01/11/2017
01/11/2017 06:00:00 PM UTC-0500
82.39 525,633
01/10/2017
01/10/2017 06:00:00 PM UTC-0500
81.93 902,876

Vertex Pharmaceuticals Peer Group

Abbott Laboratories 40.76
-0.3%
AstraZeneca 45.76
1.0%
Bayer 101.90
1.2%
Bristol-Myers Squibb 56.07
-0.4%
GlaxoSmithKline 15.60
0.5%
Merck 61.17
-0.5%
Novartis 72.15
1.0%
Pfizer 32.03
-0.1%
Vertex Pharmaceuticals 82.52
1.2%

Similar shares with higher 1-year perf.